Consensus clinical management guidelines for Niemann-Pick disease type C

. 2018 Apr 06 ; 13 (1) : 50. [epub] 20180406

Jazyk angličtina Země Velká Británie, Anglie Médium electronic

Typ dokumentu časopisecké články, práce podpořená grantem, přehledy

Perzistentní odkaz   https://www.medvik.cz/link/pmid29625568

Grantová podpora
2012 12 01 Consumers, Health, Agriculture and Food Executive Agency - International

E-zdroje Online Plný text
Odkazy

PubMed 29625568
PubMed Central PMC5889539
DOI 10.1186/s13023-018-0785-7
PII: 10.1186/s13023-018-0785-7
Knihovny.cz E-zdroje

Niemann-Pick Type C (NPC) is a progressive and life limiting autosomal recessive disorder caused by mutations in either the NPC1 or NPC2 gene. Mutations in these genes are associated with abnormal endosomal-lysosomal trafficking, resulting in the accumulation of multiple tissue specific lipids in the lysosomes. The clinical spectrum of NPC disease ranges from a neonatal rapidly progressive fatal disorder to an adult-onset chronic neurodegenerative disease. The age of onset of the first (beyond 3 months of life) neurological symptom may predict the severity of the disease and determines life expectancy.NPC has an estimated incidence of ~ 1: 100,000 and the rarity of the disease translate into misdiagnosis, delayed diagnosis and barriers to good care. For these reasons, we have developed clinical guidelines that define standard of care for NPC patients, foster shared care arrangements between expert centres and family physicians, and empower patients. The information contained in these guidelines was obtained through a systematic review of the literature and the experiences of the authors in their care of patients with NPC. We adopted the Appraisal of Guidelines for Research & Evaluation (AGREE II) system as method of choice for the guideline development process. We made a series of conclusive statements and scored them according to level of evidence, strengths of recommendations and expert opinions. These guidelines can inform care providers, care funders, patients and their carers of best practice of care for patients with NPC. In addition, these guidelines have identified gaps in the knowledge that must be filled by future research. It is anticipated that the implementation of these guidelines will lead to a step change in the quality of care for patients with NPC irrespective of their geographical location.

Zobrazit více v PubMed

Brouwers MC, Kho ME, Bowman GP, et al. AGREE II: advanced guideline development, reporting and evaluation in health care. CMAJ. 2010;182:E839–E842. doi: 10.1503/cmaj.090449. PubMed DOI PMC

Vanier MT, Duthel S, Rodriguez-Lafrasse C, Pentchev P, Carstea ED. Genetic heterogeneity in Niemann-Pick C disease: a study using somatic cell hybridization and linkage analysis. Am J Hum Genet. 1996;58:118–125. PubMed PMC

Carstea ED, Morris JA, Coleman KG, et al. Niemann-Pick C1 disease gene: homology to mediators of cholesterol homeostasis. Science. 1997;277:228–231. doi: 10.1126/science.277.5323.228. PubMed DOI

Naureckiene S, Sleat DE, Lackland H, et al. Identification of HE1 as the second gene of Niemann-Pick C disease. Science. 2000;290:2298–2301. doi: 10.1126/science.290.5500.2298. PubMed DOI

Neufeld EB, Wastney M, Patel S, et al. The Niemann-Pick C1 protein resides in a vesicular compartment linked to retrograde transport of multiple lysosomal cargo. J Biol Chem. 1999;274:9627–9635. doi: 10.1074/jbc.274.14.9627. PubMed DOI

Friedland N, Liou HL, Lobel P, Stock AM. Structure of a cholesterol-binding protein deficient in Niemann-Pick type C2 disease. Proc Natl Acad Sci U S A. 2003;100:2512–2517. doi: 10.1073/pnas.0437840100. PubMed DOI PMC

Kwon HJ, Abi-Mosleh L, Wang ML, et al. Structure of N-terminal domain of NPC1 reveals distinct subdomains for binding and transfer of cholesterol. Cell. 2009;137:1213–1224. doi: 10.1016/j.cell.2009.03.049. PubMed DOI PMC

Vanier MT. Complex lipid trafficking in Niemann-Pick disease type C. J Inherit Metab Dis. 2015;38:187–199. doi: 10.1007/s10545-014-9794-4. PubMed DOI

Imrie J, Dasgupta S, Besley GT, et al. The natural history of Niemann-Pick disease type C in the UK. J Inherit Metab Dis. 2007;30:51–59. doi: 10.1007/s10545-006-0384-7. PubMed DOI

Spiegel R, Raas-Rothschild A, Reish O, et al. The clinical spectrum of fetal Niemann-Pick type C. Am J Med Genet A. 2009;149A:446–450. doi: 10.1002/ajmg.a.32642. PubMed DOI

Vanier MT. Niemann-Pick disease type C. Orphanet J Rare Dis. 2010;5:16. doi: 10.1186/1750-1172-5-16. PubMed DOI PMC

Jahnova H, Dvorakova L, Vlaskova H, et al. Observational, retrospective study of a large cohort of patients with Niemann-Pick disease type C in the Czech Republic: a surprisingly stable diagnostic rate spanning almost 40 years. Orphanet J Rare Dis. 2014;9:140. doi: 10.1186/s13023-014-0140-6. PubMed DOI PMC

Imrie J, Heptinstall L, Knight S, Strong K. Observational cohort study of the natural history of Niemann-Pick disease type C in the UK: a 5-year update from the UK clinical database. BMC Neurol. 2015;15:257. doi: 10.1186/s12883-015-0511-1. PubMed DOI PMC

Meikle PJ, Hopwood JJ, Clague AE, Carey WF. Prevalence of lysosomal storage disorders. JAMA. 1999;281:249–254. doi: 10.1001/jama.281.3.249. PubMed DOI

Poorthuis BJ, Wevers RA, Kleijer WJ, et al. The frequency of lysosomal storage diseases in the Netherlands. Hum Genet. 1999;105:151–156. doi: 10.1007/s004399900075. PubMed DOI

Pinto R, Caseiro C, Lemos M, et al. Prevalence of lysosomal storage diseases in Portugal. Eur J Hum Genet. 2004;12:87–92. doi: 10.1038/sj.ejhg.5201044. PubMed DOI

Poupetova H, Ledvinova J, Berna L, Dvorakova L, Kozich V, Elleder M. The birth prevalence of lysosomal storage disorders in the Czech Republic: comparison with data in different populations. J Inherit Metab Dis. 2010;33:387–396. doi: 10.1007/s10545-010-9093-7. PubMed DOI PMC

Al-Jasmi FA, Tawfig N, Berniah A, et al. Prevalence and novel mutations of Lysosomal storage disorders in United Arab Emirates : LSD in UAE. JIMD Rep. 2013;10:1–9. PubMed PMC

Wassif CA, Cross JL, Iben J, et al. High incidence of unrecognized visceral/neurological late-onset Niemann-Pick disease, type C1, predicted by analysis of massively parallel sequencing data sets. Genet Med. 2016;18:41–48. doi: 10.1038/gim.2015.25. PubMed DOI PMC

Patterson MC, Mengel E, Wijburg FA, et al. Disease and patient characteristics in NP-C patients: findings from an international disease registry. Orphanet J Rare Dis. 2013;8:12. doi: 10.1186/1750-1172-8-12. PubMed DOI PMC

Trendelenburg G, Vanier MT, Maza S, et al. Niemann-Pick type C disease in a 68-year-old patient. J Neurol Neurosurg Psychiatry. 2006;77:997–998. doi: 10.1136/jnnp.2005.086785. PubMed DOI PMC

Stampfer M, Theiss S, Amraoui Y, et al. Niemann-Pick disease type C clinical database: cognitive and coordination deficits are early disease indicators. Orphanet J Rare Dis. 2013;8:35. doi: 10.1186/1750-1172-8-35. PubMed DOI PMC

Garver WS, Francis GA, Jelinek D, et al. The national Niemann-Pick C1 disease database: report of clinical features and health problems. Am J Med Genet A. 2007;143A:1204–1211. doi: 10.1002/ajmg.a.31735. PubMed DOI

Pineda M, Perez-Poyato MS, O'Callaghan M, et al. Clinical experience with miglustat therapy in pediatric patients with Niemann-Pick disease type C: a case series. Mol Genet Metab. 2010;99:358–366. doi: 10.1016/j.ymgme.2009.11.007. PubMed DOI

Schicks J, Muller Vom Hagen J, Bauer P, et al. Niemann-Pick type C is frequent in adult ataxia with cognitive decline and vertical gaze palsy. Neurology. 2013; 10.1212/WNL.0b013e31828869f9. PubMed

Abela L, Plecko B, Palla A, et al. Early co-occurrence of a neurologic-psychiatric disease pattern in Niemann-Pick type C disease: a retrospective Swiss cohort study. Orphanet J Rare Dis. 2014;9:176. doi: 10.1186/s13023-014-0176-7. PubMed DOI PMC

Sévin M, Lesca G, Baumann N, et al. The adult form of Niemann-Pick disease type C. Brain. 2007;130:120–133. doi: 10.1093/brain/awl260. PubMed DOI

Mengel E, Klünemann HH, Lourenço CM, et al. Niemann-Pick disease type C symptomatology: an expert-based clinical description. Orphanet J Rare Dis. 2013;8:166. doi: 10.1186/1750-1172-8-166. PubMed DOI PMC

Walterfang M, Fietz M, Fahey M, et al. The neuropsychiatry of Niemann-Pick type C disease in adulthood. J Neuropsychiatry Clin Neurosci. 2006;18:158–170. doi: 10.1176/jnp.2006.18.2.158. PubMed DOI

Kheder A, Scott C, Olpin S, Hadjivassiliou M. Niemann-Pick type C: a potentially treatable disorder? Pract Neurol. 2013;13:382–385. doi: 10.1136/practneurol-2013-000525. PubMed DOI

Wijburg FA, Sedel F, Pineda M, et al. Development of a suspicion index to aid diagnosis of Niemann-Pick disease type C. Neurology. 2012;78:1560–1567. doi: 10.1212/WNL.0b013e3182563b82. PubMed DOI

Yanjanin NM, Velez JI, Gropman A, et al. Linear clinical progression, independent of age of onset, in Niemann-Pick disease, type C. Am J Med Genet B Neuropsychiatr Genet. 2010;153B:132–140. PubMed PMC

Abel LA, Walterfang M, Fietz M, Bowman EA, Velakoulis D. Saccades in adult Niemann-Pick disease type C reflect frontal, brainstem, and biochemical deficits. Neurology. 2009;72:1083–1086. doi: 10.1212/01.wnl.0000345040.01917.9d. PubMed DOI

Abel LA, Bowman EA, Velakoulis D, et al. Saccadic eye movement characteristics in adult Niemann-Pick type C disease: relationships with disease severity and brain structural measures. PLoS One. 2012;7:e50947. doi: 10.1371/journal.pone.0050947. PubMed DOI PMC

Vanier MT, Gissen P, Bauer P, et al. Diagnostic tests for Niemann-Pick disease type C (NP-C): a critical review. Mol Genet Metab. 2016;118:244–254. doi: 10.1016/j.ymgme.2016.06.004. PubMed DOI

Patterson M, Clayton P, Gissen P, Anheim M, Bauer P, Bonnot O, et al. Recommendations for the detection and diagnosis of Niemann-Pick disease type C. Neurol Clin Pract. 2017;7(6):499–511. doi: 10.1212/CPJ.0000000000000399. PubMed DOI PMC

Porter FD, Scherrer DE, Lanier MH, et al. Cholesterol oxidation products are sensitive and specific blood-based biomarkers for Niemann-Pick C1 disease. Sci Transl Med. 2010;2:56ra81. doi: 10.1126/scitranslmed.3001417. PubMed DOI PMC

Jiang X, Sidhu R, Porter FD, et al. A sensitive and specific LC-MS/MS method for rapid diagnosis of Niemann-Pick C1 disease from human plasma. J Lipid Res. 2011;52:1435–1445. doi: 10.1194/jlr.D015735. PubMed DOI PMC

Welford RW, Garzotti M, Lourenço C, et al. Plasma lysosphingomyelin demonstrates great potential as a diagnostic biomarker for Niemann-Pick disease type C in a retrospective study. PLoS One. 2014;9:e114669. doi: 10.1371/journal.pone.0114669. PubMed DOI PMC

Giese AK, Mascher H, Grittner U, et al. A novel, highly sensitive and specific biomarker for Niemann-Pick type C1 disease. Orphanet J Rare Dis. 2015;10:78. doi: 10.1186/s13023-015-0274-1. PubMed DOI PMC

Kuchar L, Sikora J, Gulinello ME, et al. Quantitation of plasmatic lysosphingomyelin and lysosphingomyelin-509 for differential screening of Niemann-Pick a/B and C diseases. Anal Biochem. 2017;525:73–77. doi: 10.1016/j.ab.2017.02.019. PubMed DOI

Pettazzoni M, Froissart R, Pagan C, et al. LC-MS/MS multiplex analysis of lysosphingolipids in plasma and amniotic fluid: a novel tool for the screening of sphingolipidoses and Niemann-Pick type C disease. PLoS One. 2017;12:e0181700. doi: 10.1371/journal.pone.0181700. PubMed DOI PMC

Polo G, Burlina AP, Kolamunnage TB, et al. Diagnosis of sphingolipidoses: a new simultaneous measurement of lysosphingolipids by LC-MS/MS. Clin Chem Lab Med. 2017;55:403–414. doi: 10.1515/cclm-2016-0340. PubMed DOI

Voorink-Moret M, Goorden SMI, van Kuilenburg, A B P, Wijburg FA, Ghauharali-van der Vlugt, J M M, Beers-Stet FS, et al. Rapid screening for lipid storage disorders using biochemical markers. Expert center data and review of the literature. Mol Genet Metab. 2018;123(2):76–84. PubMed

Jiang X, Sidhu R, Mydock-McGrane L, et al. Development of a bile acid-based newborn screen for Niemann-Pick disease type C. Sci Transl Med. 2016;8:337ra63. doi: 10.1126/scitranslmed.aaf2326. PubMed DOI PMC

Mazzacuva F, Mills P, Mills K, et al. Identification of novel bile acids as biomarkers for the early diagnosis of Niemann-Pick C disease. FEBS Lett. 2016;590:1651–1662. doi: 10.1002/1873-3468.12196. PubMed DOI PMC

Patterson MC, Hendriksz CJ, Walterfang M, Sedel F, Vanier MT, Wijburg F. Recommendations for the diagnosis and management of Niemann-Pick disease type C: an update. Mol Genet Metab. 2012;106:330–344. doi: 10.1016/j.ymgme.2012.03.012. PubMed DOI

Millat G, Marcais C, Rafi MA, et al. Niemann-Pick C1 disease: the I1061T substitution is a frequent mutant allele in patients of western European descent and correlates with a classic juvenile phenotype. Am J Hum Genet. 1999;65:1321–1329. doi: 10.1086/302626. PubMed DOI PMC

Gelsthorpe ME, Baumann N, Millard E, et al. Niemann-Pick type C1 I1061T mutant encodes a functional protein that is selected for endoplasmic reticulum-associated degradation due to protein misfolding. J Biol Chem. 2008;283:8229–8236. doi: 10.1074/jbc.M708735200. PubMed DOI PMC

Millat G, Marçais C, Tomasetto C, et al. Niemann-Pick C1 disease: correlations between NPC1 mutations, levels of NPC1 protein, and phenotypes emphasize the functional significance of the putative sterol-sensing domain and of the cysteine-rich luminal loop. Am J Hum Genet. 2001;68:1373–1385. doi: 10.1086/320606. PubMed DOI PMC

Vanier MT, Latour P. Laboratory diagnosis of Niemann-Pick disease type C: the filipin staining test. Methods Cell Biol. 2015;126:357–375. doi: 10.1016/bs.mcb.2014.10.028. PubMed DOI

Reunert J, Fobker M, Kannenberg F, et al. Rapid diagnosis of 83 patients with Niemann-Pick type C disease and related cholesterol transport disorders by Cholestantriol screening. EBioMed. 2016;4:170–5. PubMed PMC

Romanello M, Zampieri S, Bortolotti N, et al. Comprehensive evaluation of plasma 7-ketocholesterol and cholestan-3beta,5alpha,6beta-triol in an Italian cohort of patients affected by Niemann-Pick disease due to NPC1 and SMPD1 mutations. Clin Chim Acta. 2016;455:39–45. doi: 10.1016/j.cca.2016.01.003. PubMed DOI

Walterfang M, Abel LA, Desmond P, Fahey MC, Bowman EA, Velakoulis D. Cerebellar volume correlates with saccadic gain and ataxia in adult Niemann-Pick type C. Mol Genet Metab. 2013;108:85–89. doi: 10.1016/j.ymgme.2012.11.009. PubMed DOI

Walterfang M, Patenaude B, Abel LA, et al. Subcortical volumetric reductions in adult Niemann-Pick disease type C: a cross-sectional study. AJNR Am J Neuroradiol. 2013;34:1334–1340. doi: 10.3174/ajnr.A3356. PubMed DOI PMC

Walterfang M, Fahey M, Desmond P, et al. White and gray matter alterations in adults with Niemann-Pick disease type C: a cross-sectional study. Neurology. 2010;75:49–56. doi: 10.1212/WNL.0b013e3181e6210e. PubMed DOI

Walterfang M, Fahey M, Abel L, et al. Size and shape of the corpus callosum in adult Niemann-Pick type C reflects state and trait illness variables. AJNR Am J Neuroradiol. 2011;32:1340–1346. doi: 10.3174/ajnr.A2490. PubMed DOI PMC

Walterfang M, Macfarlane MD, Looi JC, et al. Pontine-to-midbrain ratio indexes ocular-motor function and illness stage in adult Niemann-Pick disease type C. Eur J Neurol. 2011;19:462–467. doi: 10.1111/j.1468-1331.2011.03545.x. PubMed DOI

Chiba Y, Komori H, Takei S, Hasegawa-Ishii S, Kawamura N, Adachi K, et al. Niemann-Pick disease type C1 predominantly involving the frontotemporal region, with cortical and brainstem Lewy bodies: An autopsy case. Neuropathology. 2014;34(1):49–57. PubMed

Patterson MC, Mengel E, Vanier MT, et al. Stable or improved neurological manifestations during miglustat therapy in patients from the international disease registry for Niemann-Pick disease type C: an observational cohort study. Orphanet J Rare Dis. 2015;10:65. doi: 10.1186/s13023-015-0284-z. PubMed DOI PMC

Patterson MC, Vecchio D, Prady H, Abel L, Wraith JE. Miglustat for treatment of Niemann-Pick C disease: a randomised controlled study. Lancet Neurol. 2007;6:765–772. doi: 10.1016/S1474-4422(07)70194-1. PubMed DOI

Wraith JE, Guffon N, Rohrbach M, et al. Natural history of Niemann-Pick disease type C in a multicentre observational retrospective cohort study. Mol Genet Metab. 2009;98:250–254. doi: 10.1016/j.ymgme.2009.06.009. PubMed DOI

Wraith JE, Vecchio D, Jacklin E, et al. Miglustat in adult and juvenile patients with Niemann-Pick disease type C: long-term data from a clinical trial. Mol Genet Metab. 2010;99:351–357. doi: 10.1016/j.ymgme.2009.12.006. PubMed DOI

Héron B, Valayannopoulos V, Baruteau J, et al. Miglustat therapy in the French cohort of paediatric patients with Niemann-Pick disease type C. Orphanet J Rare Dis. 2012;7:36. doi: 10.1186/1750-1172-7-36. PubMed DOI PMC

Melancon S, Clarke J, Sirrs S, Prasad C, Mackrell M, Maranda B, et al. Niemann-Pick type C (NPC): Canadian Management Guidelines. 2015; Available at: http://www.garrod.ca/wp-content/uploads/NPC-Canadian-Guidelines-June-5-2015.pdf.

Biegstraaten M, Arngrimsson R, Barbey F, et al. Recommendations for initiation and cessation of enzyme replacement therapy in patients with Fabry disease: the European Fabry working group consensus document. Orphanet J Rare Dis. 2015;10:3. doi: 10.1186/s13023-015-0253-6. PubMed DOI PMC

Ory DS, Ottinger EA, Farhat NY, et al. Intrathecal 2-hydroxypropyl-beta-cyclodextrin decreases neurological disease progression in Niemann-Pick disease, type C1: a non-randomised, open-label, phase 1-2 trial. Lancet. 2017;390:1758–1768. doi: 10.1016/S0140-6736(17)31465-4. PubMed DOI PMC

Patterson MC, Di Bisceglie AM, Higgins JJ, et al. The effect of cholesterol-lowering agents on hepatic and plasma cholesterol in Niemann-Pick disease type C. Neurology. 1993;43:61–64. doi: 10.1212/WNL.43.1_Part_1.61. PubMed DOI

Schiffmann R. Niemann-Pick disease type C. From bench to bedside. JAMA. 1996;276:56. doi: 10.1001/jama.1996.03540070057031. PubMed DOI

Vanier MT, Rodriguez-Lafrasse C, Rousson R, et al. Type C Niemann-Pick disease: biochemical aspects and phenotypic heterogeneity. Dev Neurosci. 1991;13:307–314. doi: 10.1159/000112178. PubMed DOI

Fernandez-Valero EM, Ballart A, Iturriaga C, et al. Identification of 25 new mutations in 40 unrelated Spanish Niemann-Pick type C patients: genotype-phenotype correlations. Clin Genet. 2005;68:245–254. doi: 10.1111/j.1399-0004.2005.00490.x. PubMed DOI

Macias-Vidal J, Gort L, Lluch M, Pineda M, Coll MJ. Nonsense-mediated mRNA decay process in nine alleles of Niemann-Pick type C patients from Spain. Mol Genet Metab. 2009;97:60–64. doi: 10.1016/j.ymgme.2009.01.007. PubMed DOI

Macias-Vidal J, Rodriguez-Pascau L, Sanchez-Olle G, et al. Molecular analysis of 30 Niemann-Pick type C patients from Spain. Clin Genet. 2011;80:39–49. doi: 10.1111/j.1399-0004.2010.01504.x. PubMed DOI

Tarugi P, Ballarini G, Bembi B, et al. Niemann-Pick type C disease: mutations of NPC1 gene and evidence of abnormal expression of some mutant alleles in fibroblasts. J Lipid Res. 2002;43:1908–1919. doi: 10.1194/jlr.M200203-JLR200. PubMed DOI

Fancello T, Dardis A, Rosano C, et al. Molecular analysis of NPC1 and NPC2 gene in 34 Niemann-Pick C Italian patients: identification and structural modeling of novel mutations. Neurogenetics. 2009;10:229–239. doi: 10.1007/s10048-009-0175-3. PubMed DOI

Wraith JE, Baumgartner MR, Bembi B, et al. Recommendations on the diagnosis and management of Niemann-Pick disease type C. Mol Genet Metab. 2009;98:152–165. doi: 10.1016/j.ymgme.2009.06.008. PubMed DOI

Miao N, Lu X, O'Grady NP, Yanjanin N, Porter FD, Quezado ZM. Niemann-Pick disease type C: implications for sedation and anesthesia for diagnostic procedures. J Child Neurol. 2012;27:1541–1546. doi: 10.1177/0883073812437243. PubMed DOI PMC

Shin J, Epperson K, Yanjanin NM, et al. Defining natural history: assessment of the ability of college students to aid in characterizing clinical progression of Niemann-Pick disease, type C. PLoS One. 2011;6:e23666. doi: 10.1371/journal.pone.0023666. PubMed DOI PMC

Bonnot O, Klünemann HH, Sedel F, Tordjman S, Cohen D, Walterfang M. Diagnostic and treatment implications of psychosis secondary to treatable metabolic disorders in adults: a systematic review. Orphanet J Rare Dis. 2014;9:65. doi: 10.1186/1750-1172-9-65. PubMed DOI PMC

Klarner B, Klünemann HH, Lurding R, Aslanidis C, Rupprecht R. Neuropsychological profile of adult patients with Niemann-Pick C1 (NPC1) mutations. J Inherit Metab Dis. 2007;30:60–67. doi: 10.1007/s10545-006-0417-6. PubMed DOI

King KA, Gordon-Salant S, Yanjanin N, et al. Auditory phenotype of Niemann-Pick disease, type C1. Ear Hear. 2014;35:110–117. doi: 10.1097/AUD.0b013e3182a362b8. PubMed DOI PMC

Fecarotta S, Amitrano M, Romano A, et al. The videofluoroscopic swallowing study shows a sustained improvement of dysphagia in children with Niemann-Pick disease type C after therapy with miglustat. Am J Med Genet A. 2011;155A:540–547. doi: 10.1002/ajmg.a.33847. PubMed DOI

Galanaud D, Tourbah A, Lehericy S, et al. 24 month-treatment with miglustat of three patients with Niemann-Pick disease type C: follow up using brain spectroscopy. Mol Genet Metab. 2009;96:55–58. doi: 10.1016/j.ymgme.2008.10.002. PubMed DOI

Scheel M, Abegg M, Lanyon LJ, Mattman A, Barton JJ. Eye movement and diffusion tensor imaging analysis of treatment effects in a Niemann-Pick Type C patient. Mol Genet Metab. 2010;99(3):291–95. PubMed

Sedel F, Chabrol B, Audoin B, et al. Normalisation of brain spectroscopy findings in Niemann-Pick disease type C patients treated with miglustat. J Neurol. 2016;263:927–936. doi: 10.1007/s00415-016-8051-1. PubMed DOI PMC

Najít záznam

Citační ukazatele

Možnosti archivace